Rankings
▼
Calendar
IRWD FY 2024 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$629M
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$351M
-20.6% YoY
Gross Profit
$344M
97.9% margin
Operating Income
$93M
26.5% margin
Net Income
$880,000
0.3% margin
EPS (Diluted)
$0.01
Cash Flow
Operating Cash Flow
$104M
Free Cash Flow
$103M
Stock-Based Comp.
$30M
Balance Sheet
Total Assets
$351M
Total Liabilities
$652M
Stockholders' Equity
-$301M
Cash & Equivalents
$89M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$351M
$443M
-20.6%
Gross Profit
$344M
$437M
-21.2%
Operating Income
$93M
-$945M
+109.8%
Net Income
$880,000
-$1.0B
+100.1%
← Q4 2023
All Quarters
Q1 2024 →